Chemotherapy With Cetuximab in Treating Patients With Recurrent or Metastatic Head and Neck Cancer

Clinical trial NCT01289522 · COMPLETED

Trial details

NCT number: NCT01289522
Sponsor: Groupe Oncologie Radiotherapie Tete et Cou
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Squamous Cell Head and Neck Carcinoma Recurrent or Metastatic Disease

Start date: 2009-09-01
Primary completion: 2014-01-01
Enrollment: 54

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.